What is he best known for?
The fields of study he is best known for:
Peter F. Billingsley spends much of his time researching Malaria, Plasmodium falciparum, Virology, PfSPZ vaccine and Immunology.
His Malaria study incorporates themes from Vector and Polymerase chain reaction.
His studies deal with areas such as Genetics and Mating as well as Plasmodium falciparum.
His Virology research includes elements of Malaria vaccine, Blood meal and Microbiology.
His PfSPZ vaccine research includes themes of Immunization, Reactogenicity, Vaccine efficacy, Vaccination and Placebo.
His biological study focuses on Immune system.
His most cited work include:
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine (517 citations)
- Biology of the Insect Midgut (384 citations)
- Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity (369 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Malaria, Plasmodium falciparum, Virology, Immunology and PfSPZ vaccine.
The concepts of his Malaria study are interwoven with issues in Vector, Immunization and Clinical trial.
His work on Parasitemia as part of general Plasmodium falciparum research is frequently linked to Infectivity, thereby connecting diverse disciplines of science.
His work carried out in the field of Virology brings together such families of science as Gametocyte and Aseptic processing.
His Immune system, Vaccination, Immunity and Intradermal injection study in the realm of Immunology connects with subjects such as Syringe.
As part of one scientific family, Peter F. Billingsley deals mainly with the area of PfSPZ vaccine, narrowing it down to issues related to the Internal medicine, and often Placebo and Gastroenterology.
He most often published in these fields:
- Malaria (59.68%)
- Plasmodium falciparum (41.13%)
- Virology (37.90%)
What were the highlights of his more recent work (between 2016-2021)?
- Malaria (59.68%)
- Plasmodium falciparum (41.13%)
- PfSPZ vaccine (19.35%)
In recent papers he was focusing on the following fields of study:
Peter F. Billingsley mainly investigates Malaria, Plasmodium falciparum, PfSPZ vaccine, Malaria vaccine and Immunology.
His study in the field of Circumsporozoite protein also crosses realms of Context.
Peter F. Billingsley interconnects Acquired immune system, Plasmodium berghei, Real-time polymerase chain reaction and Virology in the investigation of issues within Plasmodium falciparum.
His studies in PfSPZ vaccine integrate themes in fields like Regimen, Internal medicine, Immunogenicity and Vaccine efficacy, Vaccination.
His Malaria vaccine study combines topics from a wide range of disciplines, such as Clinical research, Immunization and Family medicine.
His research in Immunology is mostly concerned with Chloroquine.
Between 2016 and 2021, his most popular works were:
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccine (192 citations)
- Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial (135 citations)
- Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection (117 citations)
In his most recent research, the most cited papers focused on:
Peter F. Billingsley mainly focuses on Malaria, PfSPZ vaccine, Plasmodium falciparum, Virology and Immunology.
His work in Malaria covers topics such as Regimen which are related to areas like Tolerability and Immunogenicity.
His studies in PfSPZ vaccine integrate themes in fields like Placebo, Internal medicine and Vaccine efficacy, Vaccination.
Peter F. Billingsley works on Plasmodium falciparum which deals in particular with Parasitemia.
His Virology study combines topics from a wide range of disciplines, such as Malaria vaccine and Immunization.
The various areas that Peter F. Billingsley examines in his Malaria vaccine study include Chloroquine, Mefloquine and Chemoprophylaxis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
